RE:QuarterDid you assume the same CC Pharma as last time? They had one time costs and it was 4-5 million lower between that and the exchange rate. Q4 CC Pharma was 99 m. 135-140 M would be great. Expectations are around 130 M. Most important is to demonstrate a solid plan on how guidance will be achieved. Supply deal or JV needed
Outhere wrote: This past quarter which we're waiting on to happen next week will have an impact from Alefia contract being terminated. That said, I am hearing we saw an increase in sales of 20% plus percent with rec cannabis. That would put us around 132mm.
I have not followed the Euro, so not sure how that will impact us.